Patchouli alcohol improved diarrhea-predominant irritable bowel syndrome by regulating excitatory neurotransmission in the myenteric plexus of rats

Wanyu Chen, Lu Liao, Zitong Huang, Yu-Lin Lu, Yukang Lin, Ying Pei, Shu-Lin Yi, Chen Huang, Hongying Cao, Bo TanFrontiers in Pharmacology 2022 · DOI

Abstract

Background and Purpose: Irritable bowel syndrome (IBS), particularly the diarrhea-predominant subtype (IBS-D), is a chronic gastrointestinal disorder linked to enteric nervous system (ENS) dysfunction. Patchouli alcohol (PA), derived from Pogostemonis Herba, is known to regulate neurotransmitter release, but its efficacy against IBS-D has remained unexplored.

Experimental Approach: This study utilized a rat model of IBS-D induced by chronic restraint stress. Rats were treated with varying doses of PA (5, 10, and 20 mg/kg). Researchers conducted intestinal and visceral examinations alongside immunohistochemical analysis of longitudinal muscle myenteric plexus (LMMP) neurons to assess neurotransmitter levels and neuronal morphology.

Key Results: PA treatment significantly decreased visceral sensitivity, diarrheal symptoms, and intestinal transit rates. Specifically, higher doses (10 and 20 mg/kg) reduced the proportion of excitatory LMMP neurons and restored levels of acetylcholine (Ach) and substance P (SP) in the distal colon.

Conclusion: PA modulates excitatory neuronal activity in the LMMP, suggesting it is a viable therapeutic candidate for managing IBS-D symptoms.

Introduction

Irritable bowel syndrome (IBS) affects a significant portion of the global population, with IBS-D being the most prevalent subtype. The Enteric Nervous System (ENS), often referred to as the "second brain," is central to this disorder. In IBS-D, the ENS becomes hyperactive, leading to increased visceral pain and rapid intestinal transit. Current treatments often manage symptoms without addressing the underlying neurological remodeling. This study investigates whether patchouli alcohol (PA) can effectively treat IBS-D by modulating the specific neuronal circuits responsible for gut motility.

Experimental Approach

Researchers employed a multi-level experimental approach using Sprague-Dawley rats:

  • Model Induction: Rats underwent chronic restraint stress (2 hours daily for 14 days) to mimic stress-induced human IBS.
  • Treatment: PA was administered via gavage at doses of 5, 10, and 20 mg/kg for two weeks.
  • Physiological Testing: Visceral sensitivity was measured via the Abdominal Withdrawal Reflex (AWR), and intestinal transit was tracked using carbon powder markers.
  • Molecular and Cellular Analysis: The team isolated the Longitudinal Muscle Myenteric Plexus (LMMP) for immunofluorescence microscopy and used qPCR and Western Blotting to measure Choline Acetyltransferase (ChAT) and Substance P (SP) expression.

Key Results and Discussion

Physiological Impact of the IBS-D Model

The chronic restraint stress model successfully induced the hallmarks of IBS-D. As shown in the physiological assessments, stressed rats exhibited significantly higher visceral sensitivity (AWR scores), increased fecal areas (indicative of diarrhea), and accelerated transit rates compared to control groups.

Physiological characterization of the IBS-D rat model, showing increased visceral sensitivity (A), fecal area (B), and intestinal transit rate (C) at day 28.

Therapeutic Effects of Patchouli Alcohol

PA treatment demonstrated a clear dose-dependent improvement in these physiological markers:

  • Visceral Sensitivity: Doses of 10 and 20 mg/kg significantly reduced AWR scores, effectively lowering abdominal pain levels.
  • Intestinal Transit: The transit rate in IBS-D rats (65.9%) was successfully slowed back toward control levels (59.5%) following PA administration.
  • Neurotransmitter Regulation: The study confirmed that IBS-D involves physical remodeling of the ENS. PA reversed the stress-induced overgrowth of excitatory neurons in the distal colon, significantly reducing the protein expression of ChAT and SP.
  • Morphological Restoration: Confocal imaging revealed that PA reduced the abnormally enlarged "varicosity area" of substance P-positive fibers, restoring signaling hub morphology toward baseline.

Conclusion and Future Directions

These findings indicate that PA alleviates IBS-D by dampening hyperactive excitatory neurotransmission in the distal colon. While the results are promising, the study's small sample size ($n=6$ per group) and the complexity of the ENS suggest that further research is needed. Future studies utilizing single-cell transcriptomics could provide deeper insights into how PA influences the crosstalk between gut neurons and the immune system, paving the way for human clinical trials.

Summary updated

Abstract

<b>Background and Purpose:</b> Irritable bowel syndrome (IBS) is usually associated with chronic gastrointestinal disorders. Its most common subtype is accompanied with diarrhea (IBS-D). The enteric nervous system (ENS) modulates major gastrointestinal motility and functions whose aberration may induce IBS-D. The enteric neurons are susceptible to long-term neurotransmitter level alterations. The patchouli alcohol (PA), extracted from <i>Pogostemonis Herba</i>, has been reported to regulate neurotransmitter release in the ENS, while its effectiveness against IBS-D and the underlying mechanism remain unknown. <b>Experimental Approach:</b> In this study, we established an IBS-D model in rats through chronic restraint stress. We administered the rats with 5, 10, and 20 mg/kg of PA for intestinal and visceral examinations. The longitudinal muscle myenteric plexus (LMMP) neurons were further immunohistochemically stained for quantitative, morphological, and neurotransmitters analyses. <b>Key Results:</b> We found that PA decreased visceral sensitivity, diarrhea symptoms and intestinal transit in the IBS-D rats. Meanwhile, 10 and 20 mg/kg of PA significantly reduced the proportion of excitatory LMMP neurons in the distal colon, decreased the number of acetylcholine (Ach)- and substance P (SP)-positive neurons in the distal colon and restored the levels of Ach and SP in the IBS-D rats. <b>Conclusion and Implications:</b> These findings indicated that PA modulated LMMP excitatory neuron activities, improved intestinal motility and alleviated IBS-induced diarrheal symptoms, suggesting the potential therapeutic efficacy of PA against IBS-D.
BibTeX
@inproceedings{chen2022patchouli,
  author = {Wanyu Chen and Lu Liao and Zitong Huang and Yu-Lin Lu and Yukang Lin and Ying Pei and Shu-Lin Yi and Chen Huang and Hongying Cao and Bo Tan},
  title = {{Patchouli alcohol improved diarrhea-predominant irritable bowel syndrome by regulating excitatory neurotransmission in the myenteric plexus of rats}},
  booktitle = {Frontiers in Pharmacology},
  year = {2022},
  doi = {10.3389/fphar.2022.943119},
}
Figure